Strategy - Pharmaceutical Executive

ADVERTISEMENT

Strategy
The art and science of running a successful pharmaceutical company.

Dane in America

November 1, 2014

Jesper Hoiland, Novo Nordisk's President for North America, assesses the challenges and opportunities during his first year at the helm of the diabetes franchise leader's biggest affiliate market.

Gravity Shift: What MNCs Can Learn from Generics

May 15, 2014

MNCs can learn a lot from generic companies in their strategic approaches to emerging markets.

Regional Trends in Bioinnovation Investment

April 16, 2014

California's Bay Area and the Boston/Cambridge nexus continue to dominate bioinnovation in the US. Pharm Exec looks at the factors contributing to the strategic dominance of these regions.

The New Metrics of Market Success

March 3, 2014

Profitability now depends on metrics to help companies answer a key strategic question: "stay the course" with more investment in sales and marketing? Or "stand down" and deploy those scarce assets somewhere else?

Takeda's Oncology Taskmaster

February 1, 2014

Millennium Takeda's new president, Anna Protopapas, explains the life choices that brought her from Cyprus to Cambridge—and a lead position in the hotly contested search to make cancer a treatable disease.

Innovation: The Moneyball Test

January 21, 2014

Successful innovation now has to align with key metrics of value—can an old baseball metaphor help guide the way?

Pharm Exec's Annual Industry Outlook 2014

January 21, 2014

For Big Pharma, the merits of strategic focus and operational discipline are more important than ever. It is time to be decisive — muddling through is so yesterday.

Pharm Exec Roundtable on Market Access

November 25, 2013

Pharm Exec convenes a diverse panel of experts to identify the key markers of common ground: its time, people, and money against that greatest intangible—hope.

Outcomes Data: A Critical Insight for Market Access

October 9, 2013

Real-world pharmacoeconomic data can provide critical insight for maximizing US market access and oncology product differentiation, and should be central to the overall brand strategy of any oncology product

ADVERTISEMENT

Click here